In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. February 24, 2020

    37 AGs Assail Plaintiffs' Atty Fee Bid In Opioid MDL

    A group of 37 attorneys general urged an Ohio federal judge Monday to reject a fee request from lead plaintiffs' attorneys in the opioid multidistrict litigation, saying it could irreparably disrupt progress made toward reaching a large national settlement.

  2. February 24, 2020

    Architect Of Opioid MDL 'Negotiation Class' Dies Suddenly

    Francis McGovern, one of the three special masters in the opioid multidistrict litigation, who played a key role in crafting a novel "negotiation class" with the aim of seeking a nationwide deal, recently died at the age of 75.

  3. February 21, 2020

    Opioid Cos. Must Face Benefit Plans' Suit In MDL

    The Ohio federal judge overseeing the opioid multidistrict litigation allowed union benefit plans to go forward with their suit alleging that opioid companies created a public nuisance, finding that they claim injuries different from the harm to health and safety suffered by the general public.

  4. February 18, 2020

    States Rip Opioid Judge For Creating Class Action By 'Decree'

    An Ohio federal judge's creation of a "negotiation class" intended to help resolve the multidistrict opioid litigation subverts state governmental authority by allowing potentially every U.S. city and county to strike global settlements with drug companies, a coalition of states told the Sixth Circuit.

  5. February 13, 2020

    6th Circ. Halts Nationwide Discovery In Opioid MDL

    The Sixth Circuit on Thursday paused nationwide discovery in the opioid multidistrict litigation as the panel considers a petition by pharmacies that claims the Ohio judge presiding over the litigation repeatedly flouted federal court rules.

  6. February 13, 2020

    Pharmacies Must Give Patient Ages In Opioid MDL Discovery

    An Ohio federal judge on Thursday overruled objections from several pharmacies being asked to disclose the ages of patients in discovery in sprawling opioid multidistrict litigation, saying in light of the other data being produced, disclosing the ages does not present a risk to patient privacy.

  7. February 07, 2020

    Opioid MDL 'Negotiation Class' Gets Bombarded At 6th Circ.

    Drug distributors and cities fired away Friday at a "negotiation class" intended to help resolve the multidistrict opioid litigation, telling the Sixth Circuit that the unprecedented approach flouts class action procedures and is tainted by attorney conflicts of interest.

  8. February 05, 2020

    JPML Ships Opioid Bellwethers Over Drug Co. Protests

    The Judicial Panel on Multidistrict Litigation on Wednesday moved opioid-crisis cases involving San Francisco and a major Native American tribe to federal courts in California and Oklahoma, rejecting strident objections from drug companies and teeing up dramatic bellwether trials.

  9. January 30, 2020

    Opioid MDL's Pharmacy Bellwether Trial Nudged To November

    The Ohio federal judge overseeing multidistrict opioid litigation has moved back to November an eagerly awaited bellwether trial targeting the nation's largest pharmacy chains, a top plaintiffs' attorney in the MDL said Thursday.

  10. January 28, 2020

    Opioid MDL Special Master Sets Data Production Guidelines

    A special master in the opioid multidistrict litigation in Ohio on Monday outlined what data pharmacies have to turn over to local governments in the litigation, including information on non-opioids that are associated with "doctor-shopping."

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!